Close
American Drug Delivery & Formulation Summit
Xylem

Alto Pharma to introduce DermSafe hand sanitizer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

How Modern Wellness Research Is Shaping Health Innovation

Science has always driven progress in health, but the...

The Starting Material Dilemma: De-Risking Early-Stage CAR-T and Immuno-Oncology Pipelines

The Operational Bottleneck in Advanced Therapeutics The cell and gene...

Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets

A new research project from the Johns Hopkins Bloomberg...
- Advertisement -

Alto Pharmaceuticals is set to introduce Skinvisible Pharmaceuticals’ DermSafe antimicrobial hand sanitizer in Canada on 1 September 2011.Under an agreement signed between both the companies, Skinvisible has given Canadian marketing rights of DermSafe to Alto. Alto expects to market the product under the name DermSafePC.DermSafe is made with 4% chlorhexidine gluconate and it does not contain delivers protection in a lotion formulation that defends the skin from outside irritants.Skinvisible president and CEO Terry Howlett said they believe that the introduction of DermSafePC will help generate a very positive response from end-users as well as potential licensees worldwide.

“The manufacturing of DermSafe in Canada is critical to Skinvisible as it will facilitate the quick introduction of the product in Europe and Singapore, where DermSafe is already approved for importation,” Howlett said.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

How Modern Wellness Research Is Shaping Health Innovation

Science has always driven progress in health, but the...

The Starting Material Dilemma: De-Risking Early-Stage CAR-T and Immuno-Oncology Pipelines

The Operational Bottleneck in Advanced Therapeutics The cell and gene...

Study Identifies Tiered Manufacturing in Global Pharmaceutical Markets

A new research project from the Johns Hopkins Bloomberg...

Enclomiphene Dosage and What to Expect in the First 90 Days

You have decided to try enclomiphene. Now what? For many...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป